Morning Market Losers
October 06, 2014 at 09:47 AM EDT
Sunesis Pharmaceuticals (NASDAQ: SNSS) shares dipped 69.88% to $2.00 as pivotal Phase 3 VALOR trial of acute myeloid leukemia treatment ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.